// App-Quantinova.ai

: Rivaroxaban for Heparin‐induced Thrombocytopenia ‐ Safety and Efficacy Updates from a Case Series

Researchers

Presenter

  • Y. Tan

Principal Investigators

  • S.Y. Ong

  • C.W. Tan

  • W.H. Wong

  • D. Tan Yan

  • E.S. Yap

  • H.J. Ng

Medical Centers

  • Singhealth, Singapore, Singapore

  • National University Health System, Singapore, Singapore

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Platelet Factor 4

  • Immunoglobulin G

Drug/Treatment

  • rivaroxaban

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved